SYNTHETIC BIOLOGICS INC's ticker is and the CUSIP is 87164U409. A total of 23 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3 | -57.1% | 14 | 0.0% | 0.00% | – |
| Q1 2024 | $7 | +16.7% | 14 | 0.0% | 0.00% | – |
| Q4 2023 | $6 | -25.0% | 14 | 0.0% | 0.00% | – |
| Q3 2023 | $8 | -42.9% | 14 | 0.0% | 0.00% | – |
| Q2 2023 | $14 | +40.0% | 14 | 0.0% | 0.00% | – |
| Q1 2023 | $10 | +66.7% | 14 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | – | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,528 | $19,924 | 0.00% |
| ROYAL BANK OF CANADA | 7 | $0 | 0.00% |
| VANGUARD GROUP INC | 525,367 | $366,916 | 0.00% |
| Steward Partners Investment Advisory, LLC | 14 | $10 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 21 | $14 | 0.00% |
| WELLS FARGO & COMPANY/MN | 110 | $77 | 0.00% |
| NORTHERN TRUST CORP | 35,699 | $24,932 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| IFP Advisors, Inc | 382 | $572 | 0.00% |
| Fisher Asset Management, LLC | 12,569 | $8,778 | 0.00% |